Pathogenesis, Diagnosis, and Medical Management of Blood Clots
A special issue of Diagnostics (ISSN 2075-4418). This special issue belongs to the section "Pathology and Molecular Diagnostics".
Deadline for manuscript submissions: closed (15 April 2023) | Viewed by 1112
Special Issue Editor
2. Department of Neurology & Neurophysiology, Liverpool Hospital & South West Sydney Local Health District (SWSLHD), Liverpool, NSW 2170, Australia
Interests: neurology; biomarkers; clinical trials; cardiovascular diseases; stroke; telemedicine; COVID-19; neuropathology; neuroimmunology; neurodegenerative diseases; neurophysiology; clinical medicine; clinical neuroscience; public health
Special Issues, Collections and Topics in MDPI journals
Special Issue Information
Dear Colleagues,
Blood clots are a public health concern associated with significant morbidity and mortality. Blood clots in arteries, or arterial thrombosis, can manifest as ischemic stroke or ischemic heart disease. Similarly, blood clots in veins, or venous thrombosis, can present as venous thromboembolism (VTE), including pulmonary embolism (PE) and deep vein thrombosis (DVT). These conditions pose an ongoing challenge, especially in select group of patients, where aetiology cannot be determined despite extensive diagnostic work-up. This Special Issue will present a comprehensive overview of the latest advances in research into pathogenesis of blood clots as well as the diagnostics, prevention, and acute management of blood clots in clinical practice. More recently, studies suggested an increased risk of blood clots in patients with COVID-19, especially in hospitalized patients and those with moderate and severe illness. However, much remains to be delineated on the underlying mechanisms. Beyond our existing knowledge, gaps in the scientific understanding of pathogeneses, emerging avenues of future research, prevention and clinical practice variations, or improvement will also be discussed.
We invite submissions on a broad range of topics, including but not limited to cross-sectional studies, clinical trials, position paper/recommendations, hypothesis/perspective, systematic and narrative/comprehensive review. The articles in this section may be included in a forthcoming book to be published by MDPI.
Dr. Sonu M. M. Bhaskar
Guest Editor
Manuscript Submission Information
Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.
Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Diagnostics is an international peer-reviewed open access semimonthly journal published by MDPI.
Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2600 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.
Keywords
- blood clots
- stroke
- ischemic heart disease
- myocardial infarction
- venous thromboembolism
- deep vein thrombosis
- pulmonary embolism
